About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Oncogenesis
›
top-articles
Oncogenesis
5.3
(top 5%)
impact factor
799
(top 20%)
papers
26.5K
(top 10%)
citations
67
(top 10%)
h
-index
5.4
(top 5%)
impact factor
880
all documents
29.3K
doc citations
113
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Lipid metabolic reprogramming in cancer cells
Oncogenesis
2016
1,011
2
The hypoxic tumour microenvironment
Oncogenesis
2018
722
3
Epigenetic and genetic features of 24 colon cancer cell lines
Oncogenesis
2013
658
4
Hypoxia and metabolic adaptation of cancer cells
Oncogenesis
2016
572
5
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Oncogenesis
2017
422
6
Understanding cachexia as a cancer metabolism syndrome
Oncogenesis
2016
384
7
Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases
Oncogenesis
2018
373
8
Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells
Oncogenesis
2017
358
9
SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells
Oncogenesis
2013
275
10
Wnt signaling in triple-negative breast cancer
Oncogenesis
2017
217
11
A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop
Oncogenesis
2013
211
12
Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers
Oncogenesis
2017
186
13
Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation
Oncogenesis
2016
178
14
Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
Oncogenesis
2015
144
15
Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes
Oncogenesis
2015
140
16
Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway
Oncogenesis
2014
138
17
DeepCC: a novel deep learning-based framework for cancer molecular subtype classification
Oncogenesis
2019
138
18
Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google Maps
Oncogenesis
2015
129
19
MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
Oncogenesis
2013
128
20
Linking genomic reorganization to tumor initiation via the giant cell cycle
Oncogenesis
2016
121
21
Regulation of the pentose phosphate pathway by an androgen receptor–mTOR-mediated mechanism and its role in prostate cancer cell growth
Oncogenesis
2014
116
22
A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls
Oncogenesis
2016
107
23
The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy
Oncogenesis
2019
107
24
An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis
Oncogenesis
2016
106
25
Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo
Oncogenesis
2015
105
26
Tumor-derived exosomes induce PD1+ macrophage population in human gastric cancer that promotes disease progression
Oncogenesis
2018
105
27
Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET
Oncogenesis
2013
101
28
Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways
Oncogenesis
2014
101
29
An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance
Oncogenesis
2019
99
30
Long non-coding RNA LINC00152 promotes cell proliferation, metastasis, and confers 5-FU resistance in colorectal cancer by inhibiting miR-139-5p
Oncogenesis
2017
98
31
Knockdown of long non-coding RNA XIST increases blood–tumor barrier permeability and inhibits glioma angiogenesis by targeting miR-137
Oncogenesis
2017
95
32
Inhibition of ATG12-mediated autophagy by miR-214 enhances radiosensitivity in colorectal cancer
Oncogenesis
2018
95
33
NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
Oncogenesis
2013
92
34
MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulation
Oncogenesis
2016
92
35
Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins
Oncogenesis
2016
92
36
Integrative analyses of transcriptome sequencing identify novel functional lncRNAs in esophageal squamous cell carcinoma
Oncogenesis
2017
92
37
MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo
Oncogenesis
2014
91
38
Energy disruptors: rising stars in anticancer therapy?
Oncogenesis
2016
91
39
MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation
Oncogenesis
2017
91
40
Deubiquitination of Dishevelled by Usp14 is required for Wnt signaling
Oncogenesis
2013
90
41
Involvement of polypyrimidine tract-binding protein (PTBP1) in maintaining breast cancer cell growth and malignant properties
Oncogenesis
2014
90
42
Non-canonical WNT/PCP signalling in cancer: Fzd6 takes centre stage
Oncogenesis
2017
90
43
HOXC8 promotes proliferation and migration through transcriptional up-regulation of TGFβ1 in non-small cell lung cancer
Oncogenesis
2018
90
44
Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic niche
Oncogenesis
2020
89
45
Compensatory angiogenesis and tumor refractoriness
Oncogenesis
2015
88
46
Double agents: genes with both oncogenic and tumor-suppressor functions
Oncogenesis
2018
88
47
MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma
Oncogenesis
2012
87
48
Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathway
Oncogenesis
2017
87
49
Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin
Oncogenesis
2013
85
50
The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
Oncogenesis
2015
83
site/software ©
exaly
; All materials licenced under
CC by-SA
.